207 related articles for article (PubMed ID: 15160402)
1. Minimization of sample size when comparing two small probabilities in a non-inferiority safety trial.
de Boo TM; Zielhuis GA
Stat Med; 2004 Jun; 23(11):1683-99. PubMed ID: 15160402
[TBL] [Abstract][Full Text] [Related]
2. Minimization of sample size when comparing two small probabilities in a non-inferiority safety trial.
Röhmel J; Wassmer G
Stat Med; 2004 Nov; 23(21):3393-4; author reply 3395-6. PubMed ID: 15493032
[No Abstract] [Full Text] [Related]
3. Power and sample size computations in simultaneous tests for non-inferiority based on relative margins.
Dilba G; Bretz F; Hothorn LA; Guiard V
Stat Med; 2006 Apr; 25(7):1131-47. PubMed ID: 16217842
[TBL] [Abstract][Full Text] [Related]
4. Implementing a decision-theoretic design in clinical trials: why and how?
Palmer CR; Shahumyan H
Stat Med; 2007 Nov; 26(27):4939-57. PubMed ID: 17582801
[TBL] [Abstract][Full Text] [Related]
5. A framework for two-stage adaptive procedures to simultaneously test non-inferiority and superiority.
Koyama T; Sampson AR; Gleser LJ
Stat Med; 2005 Aug; 24(16):2439-56. PubMed ID: 15977285
[TBL] [Abstract][Full Text] [Related]
6. Non-inferiority trials: the 'at least as good as' criterion with dichotomous data.
Laster LL; Johnson MF; Kotler ML
Stat Med; 2006 Apr; 25(7):1115-30. PubMed ID: 16381070
[TBL] [Abstract][Full Text] [Related]
7. Sample size determination for comparing several survival curves with unequal allocations.
Halabi S; Singh B
Stat Med; 2004 Jun; 23(11):1793-815. PubMed ID: 15160409
[TBL] [Abstract][Full Text] [Related]
8. Active-controlled, non-inferiority trials in oncology: arbitrary limits, infeasible sample sizes and uninformative data analysis. is there another way?
Carroll KJ
Pharm Stat; 2006; 5(4):283-93. PubMed ID: 17128427
[TBL] [Abstract][Full Text] [Related]
9. Modified Haybittle-Peto group sequential designs for testing superiority and non-inferiority hypotheses in clinical trials.
Lai TL; Shih MC; Zhu G
Stat Med; 2006 Apr; 25(7):1149-67. PubMed ID: 16189814
[TBL] [Abstract][Full Text] [Related]
10. Comparing an experimental agent to a standard agent: relative merits of a one-arm or randomized two-arm Phase II design.
Taylor JM; Braun TM; Li Z
Clin Trials; 2006; 3(4):335-48. PubMed ID: 17060208
[TBL] [Abstract][Full Text] [Related]
11. An adjustment for patient heterogeneity in the design of two-stage phase II trials.
Sposto R; Gaynon PS
Stat Med; 2009 Sep; 28(20):2566-79. PubMed ID: 19521973
[TBL] [Abstract][Full Text] [Related]
12. A new test of non-inferiority for anti-infective trials.
Phillips KF
Stat Med; 2003 Jan; 22(2):201-12. PubMed ID: 12520557
[TBL] [Abstract][Full Text] [Related]
13. Some optimal and non-optimal two-stage designs using an alpha-spending function.
Patel HI
Stat Med; 1996 Aug; 15(16):1739-45. PubMed ID: 8870156
[TBL] [Abstract][Full Text] [Related]
14. Group sequential test strategies for superiority and non-inferiority hypotheses in active controlled clinical trials.
Wang SJ; Hung HM; Tsong Y; Cui L
Stat Med; 2001 Jul; 20(13):1903-12. PubMed ID: 11427948
[TBL] [Abstract][Full Text] [Related]
15. A hybrid Bayesian-frequentist approach to evaluate clinical trial designs for tests of superiority and non-inferiority.
Shao Y; Mukhi V; Goldberg JD
Stat Med; 2008 Feb; 27(4):504-19. PubMed ID: 17854052
[TBL] [Abstract][Full Text] [Related]
16. Exact sample-size determination in testing non-inferiority under a simple crossover trial.
Lui KJ; Chang KC
Pharm Stat; 2012; 11(2):129-34. PubMed ID: 22232060
[TBL] [Abstract][Full Text] [Related]
17. Choice of lambda-margin and dependency of non-inferiority trials.
Tsong Y; Levenson M; Zhang J; Zhong J
Stat Med; 2008 Feb; 27(4):520-8. PubMed ID: 17617797
[TBL] [Abstract][Full Text] [Related]
18. A two-stage sample size recalculation procedure for placebo- and active-controlled non-inferiority trials.
Schwartz TA; Denne JS
Stat Med; 2006 Oct; 25(19):3396-406. PubMed ID: 16900573
[TBL] [Abstract][Full Text] [Related]
19. Sample sizes in the multivariate analysis of repeated measurements.
Vonesh EF; Schork MA
Biometrics; 1986 Sep; 42(3):601-10. PubMed ID: 3567293
[TBL] [Abstract][Full Text] [Related]
20. A composite design for transition from a preliminary to a full-scale study.
Lachin JM; Younes N
Stat Med; 2007 Nov; 26(27):5014-32. PubMed ID: 17577245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
